The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancerGOSSELAAR, Claartje; ROOBOL, Monique J; ROEMELING, Stijn et al.BJU international (Papier). 2008, Vol 101, Num 6, pp 685-690, issn 1464-4096, 6 p.Article

No Evidence of FGFR3 Mutations in Prostate CancerZUIVERLOON, Tahlita C. M; BOORMANS, Joost L; TRAPMAN, Jan et al.The Prostate. 2011, Vol 71, Num 6, pp 637-641, issn 0270-4137, 5 p.Article

The value of EZH2, p27^kip1, BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomyWOLTERS, Tineke; VISSERS, Kees J; BANGMA, Chris H et al.BJU international (Papier). 2010, Vol 106, Num 2, pp 280-286, issn 1464-4096, 7 p.Article

Epithelial cell differentiation in the human prostate epithelium: Implications for the pathogenesis and therapy of prostate cancerVAN LEENDERS, Geert J. L. H; SCHALKEN, Jack A.Critical reviews in oncology/hematology. 2003, Vol 46, pp S3-S10, issn 1040-8428, SUPConference Paper

Prostate Cancer Antigen 3: Diagnostic Outcomes in Men Presenting With Urinary Prostate Cancer Antigen 3 Scores ≥100SCHRÖDER, Fritz H; VENDERBOS, Lionne D. F; VAN DEN BERGH, Roderick C. N et al.Urology (Ridgewood, NJ). 2014, Vol 83, Num 3, pp 613-616, issn 0090-4295, 4 p.Article

A New and Highly Prognostic System to Discern T1 Bladder Cancer SubstageVAN RHIJN, Bas W. G; VAN DER KWAST, Theo H; ZLOTTA, Alexandre R et al.European urology. 2012, Vol 61, Num 2, pp 378-384, issn 0302-2838, 7 p.Article

Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic TestROOBOL, Monique J; SCHRÖDER, Fritz H; VAN LEEUWEN, Pim et al.European urology. 2010, Vol 58, Num 4, pp 475-481, issn 0302-2838, 7 p.Article

Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular MarkersBANGMA, Chris H; LOEB, Stacy; ZWARTHOFF, Ellen C et al.European urology. 2013, Vol 64, Num 1, pp 41-47, issn 0302-2838, 7 p.Article

Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcomeMARIJE HOOGLAND, Agnes; DAHLMAN, Anna; VISSERS, Kees J et al.BJU international (Papier). 2011, Vol 108, Num 8, pp 1356-1362, issn 1464-4096, 7 p.Article

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non-Muscle-Invasive Bladder CancerVAN RHIJN, Bas W. G; ZUIVERLOON, Tahlita C. M; ZWARTHOFF, Ellen C et al.European urology. 2010, Vol 58, Num 3, pp 433-441, issn 0302-2838, 9 p.Article

The Pathologist's Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer GradingVAN RHIJN, Bas W. G; VAN LEENDERS, Geert J. L. H; OOMS, Bert C. M et al.European urology. 2010, Vol 57, Num 6, pp 1052-1057, issn 0302-2838, 6 p.Article

A new system for substaging pT1 papillary bladder cancer : a prognostic evaluationVAN DER AA, Madelon N. M; VAN LEENDERS, Geert J. L. H; STEYERBERG, Ewout W et al.Human pathology. 2005, Vol 36, Num 9, pp 981-986, issn 0046-8177, 6 p.Article

The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancerGOOSSEN, Tjerk E. B; DE LA ROSETTE, Jean J. M. C. H; HULSBERGEN-VAN DE KAA, Christina A et al.European urology. 2003, Vol 43, Num 2, pp 124-131, issn 0302-2838, 8 p.Article

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imagingENGELBRECHT, Marc R; HUISMAN, Henkjan J; LAHEIJ, Robert J. F et al.Radiology. 2003, Vol 229, Num 1, pp 248-254, issn 0033-8419, 7 p.Article

Microvessel density: Correlation between contrast ultrasonography and histology of prostate cancer : Imaging in prostate cancerSEDELAAR, J. P; VAN LEENDERS, Geert J. L. H; HULSBERGEN-VAN DE KAA, Christian A et al.European urology. 2001, Vol 40, Num 3, pp 285-293, issn 0302-2838Article

Prostate-specific Antigen―Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate CancerBOKHORST, Leonard P; BANGMA, Chris H; VAN LEENDERS, Geert J. L. H et al.European urology. 2014, Vol 65, Num 2, pp 329-336, issn 0302-2838, 8 p.Article

The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened MenVEDDER, Moniek M; DE BEKKER-GROB, Esther W; LILJA, Hans G et al.European urology. 2014, Vol 66, Num 6, pp 1109-1115, issn 0302-2838, 7 p.Article

False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-upWOLTERS, Tineke; VAN DER KWAST, Theodorus H; VISSERS, Cornelis J et al.The American journal of surgical pathology. 2010, Vol 34, Num 1, pp 35-43, issn 0147-5185, 9 p.Article

Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate BiopsiesVAN DER KWAST, Theodorus H; EVANS, Andrew; NEETENS, Ingrid et al.The American journal of surgical pathology. 2010, Vol 34, Num 2, pp 169-177, issn 0147-5185, 9 p.Article

Tubular and interstitial nephrocalcinosisKUMMELING, Maxime T. M; DE JONG, Bas W. D; LAFFEBER, Charlie et al.The Journal of urology. 2007, Vol 178, Num 3, pp 1097-1103, issn 0022-5347, 7 p., 1Article

Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophyVAN LEENDERS, Geert J. L. H; GAGE, Wesley R; HICKS, Jessica L et al.The American journal of pathology. 2003, Vol 162, Num 5, pp 1529-1537, issn 0002-9440, 9 p.Article